Talk to Alison

00 1 718 618 48 97

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Biotechnology Analysis & Statistics, May 2011 (p50)

You might be interested in: biotech, biomedical, biomaterials, more »

» Purchase Premium Reports

1471-1500 of about 2 200 reports
Genomics Industry: Genzyme Corporation

Genomics Industry: Genzyme Corporation

  • $ 5 700
  • Industry report
  • May 2011
  • by Datamonitor

Introduction This analysis examines the historical and projection performance for Genzyme in the prescription pharmaceutical segment . The profile encompasses global industry player strategy, portfolio ...

  • Industries : Genomics
Commercializing Biomarkers in Therapeutic and Diagnostic Applications - Overview

Commercializing Biomarkers in Therapeutic and Diagnostic Applications - Overview

  • $ 3 195
  • Industry report
  • May 2011
  • by CHI Insight Pharma Reports

Biomarkers feature in thousands of published articles each year, evidencing the high level of interest and research in this field. This report focuses on issues that must be addressed to utilize this growing ...

  • Industries : Genomics
  • Countries : United States
Protein power - new foods, new markets Strategies and case studies

Protein power - new foods, new markets Strategies and case studies

  • $ 395
  • Industry report
  • May 2011
  • by The Centre for Food & Health Studies

About this report Protein is breaking out of the gym, shaking off its ?body-builder? image and moving onto the radar screen of the ?normal? consumer. Weight management is the strongest and most-used health ...

  • Industries : Biopharmaceutical, Diet Food
  • Countries : India, China
White Biotechnology

White Biotechnology

  • $ 6 000
  • Industry report
  • May 2011
  • by Frost & Sullivan

The white biotechnology market research service analyzes the food and feed industry, pharmaceutical industry, biofuel industry, bioplastics industry, and personal care industry. The current scenario in ...

  • Industries : Biotechnology
  • Countries : World
Orthopedic Biomaterials, The World Market

Orthopedic Biomaterials, The World Market

  • $ 3 995
  • Industry report
  • May 2011
  • by Kalorama Information

Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fracture to facilitate healing or to compensate for a lack or loss of bone tissue. Biomaterials ...

  • Industries : Biomaterial
  • Countries : World
Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies - A Global Market Watch, 2009-2015

Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies - A Global Market Watch, 2009-2015

  • $ 4 710
  • Industry report
  • May 2011
  • by Axis Research Mind

REPORT DESCRIPTION GLOBAL MARKET WATCH Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during ...

  • Industries : Biological Therapy
  • Countries : World
Cryopreservation Equipments in Stem Cells - A Global Market Watch, 2009-2015

Cryopreservation Equipments in Stem Cells - A Global Market Watch, 2009-2015

  • $ 3 540
  • Industry report
  • May 2011
  • by Axis Research Mind

REPORT DESCRIPTION Global Market Watch With a CAGR of 23.7%, global market value for cryopreservation equipments used in stem cells industry is anticipated to worth US$2.2 billion by 2015. On a global ...

  • Industries : Biological Therapy
  • Countries : World
European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries)

European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries)

  • $ 10 995
  • Industry report
  • May 2011
  • by iData Research, Inc.

The European orthopedic biomaterials markets are expected to approach ?1 billion by 2017, with hyaluronic acid viscosupplementation as the largest segment. The European orthopedic biomaterials markets ...

  • Industries : Biomaterial
  • Countries : Europe
European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) - Executive Summary only

European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) - Executive Summary only

  • $ 195
  • Industry report
  • May 2011
  • by iData Research, Inc.

The European orthopedic biomaterials markets are expected to approach ?1 billion by 2017, with hyaluronic acid viscosupplementation as the largest segment. The European orthopedic biomaterials markets ...

  • Industries : Biomaterial
  • Countries : Europe
What%s Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015

What%s Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015

  • $ 3 995
  • Industry report
  • May 2011
  • by Kalorama Information

The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Biological Therapy Industry: Lysosomal Storage Disorder - Pipeline Review, Q2 2011

Biological Therapy Industry: Lysosomal Storage Disorder - Pipeline Review, Q2 2011

  • $ 500
  • Company report
  • April 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Lysosomal Storage Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Biological Therapy
  • Countries : World
Biological Therapy Industry: Plasma Cell Neoplasm - Pipeline Review, Q2 2011

Biological Therapy Industry: Plasma Cell Neoplasm - Pipeline Review, Q2 2011

  • $ 500
  • Company report
  • April 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Plasma Cell Neoplasm, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Biological Therapy
  • Countries : World
Genomics Industry: Genetic Immunity, LLC - Product Pipeline Review - Q1 2011

Genomics Industry: Genetic Immunity, LLC - Product Pipeline Review - Q1 2011

  • $ 500
  • Company report
  • April 2011
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

  • Industries : Genomics
  • Countries : World
Biological Therapy Industry: Indolent Lymphoma - Pipeline Review, Q2 2011

Biological Therapy Industry: Indolent Lymphoma - Pipeline Review, Q2 2011

  • $ 500
  • Company report
  • April 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Indolent Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Biological Therapy
  • Countries : United States
Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines

Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines

  • $ 3 500
  • Industry report
  • April 2011
  • by GBI Research

Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines Summary GBI Research's pharmaceutical research, ?Biotech M&A and Licensing ...

  • Industries : Biopharmaceutical
  • Countries : World
Biological Therapy Industry: Primary Systemic Amyloidosis - Pipeline Review, Q2 2011

Biological Therapy Industry: Primary Systemic Amyloidosis - Pipeline Review, Q2 2011

  • $ 500
  • Industry report
  • April 2011
  • by Global Markets Direct

This report provides information on the therapeutic development for Primary Systemic Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Biological Therapy
  • Countries : World
Legal Services Industry: ZymoGenetics, Inc. - Strategy and SWOT Report

Legal Services Industry: ZymoGenetics, Inc. - Strategy and SWOT Report

  • $ 175
  • Company report
  • April 2011
  • by MarketLine

Datamonitors' ZymoGenetics, Inc.?s SWOT, Strategy and Corporate Finance Report, is a source of comprehensive industry player data and information. The market research report covers the firm ?s structure, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biomaterials - A Global Market Overview

Biomaterials - A Global Market Overview

  • $ 3 960
  • Industry report
  • April 2011
  • by Industry Experts

`Opting for the right material to use in a medical device is no longer a complex procedure, barring the fact that such medical devices fabricated using these materials are biocompatible, which can be ensured ...

  • Industries : Biomaterial
  • Countries : World
Biopharmaceutical in United States: Company Financials: Vical Incorporated

Biopharmaceutical in United States: Company Financials: Vical Incorporated

  • $ 75
  • Industry report
  • April 2011
  • by Datamonitor

About This Report The Firms Financials offers insights into the financial performance of the industry player over last five years for about 1000 leading global firms . The datapack covers wealth of financial ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical in United States: Company Financials: XenoPort, Inc.

Biopharmaceutical in United States: Company Financials: XenoPort, Inc.

  • $ 75
  • Industry report
  • April 2011
  • by Datamonitor

About This Report The Firms Financials offers insights into the financial performance of the industry player over last five years for about 1000 leading global firms . The datapack covers wealth of financial ...

  • Industries : Biopharmaceutical
  • Countries : United States
World Genomics: Genetic Testing Reagents

World Genomics: Genetic Testing Reagents

  • $ 3 500
  • Industry report
  • April 2011
  • by Global Data

The report provides industry landscape, competitive landscape and industry trends data on the genetic testing industry . The report provides comprehensive data on the major industry developments affecting ...

  • Industries : Genomics
  • Countries : World
Pharmacogenomic Partnering Terms and Agreements

Pharmacogenomic Partnering Terms and Agreements

  • $ 2 695
  • Industry report
  • April 2011
  • by Currentpartnering

Summary The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by ...

  • Industries : Genomics
Life Science Tools and Reagents: Global Markets

Life Science Tools and Reagents: Global Markets

  • $ 5 450
  • Industry report
  • April 2011
  • by BCC Research

The life science tools market has shown steady growth over the last couple of years despite the economic downturn. This market is currently valued at more than $42 billion and is projected to increase ...

  • Industries : Genomics
  • Countries : World
Biotechnology in India Industry

Biotechnology in India Industry

  • $ 3 950
  • Industry report
  • April 2011
  • by Global Industry Analyst

This report analyzes the market for Biotechnology in India in US$ million by the following Key Sectors - Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services. Annual estimates ...

  • Industries : Biopharmaceutical
  • Countries : India
US Stem Cell Market Analysis

US Stem Cell Market Analysis

  • $ 800
  • Industry report
  • April 2011
  • by RNCOS

The stem cell market has been growing at a fast pace for the past few years and despite recession, the US continued to witness positive developments and massive investments in this industry. Using stem ...

  • Industries : Biological Therapy
  • Countries : United States
ZymoGenetics, Inc. SWOT

ZymoGenetics, Inc. SWOT

  • $ 175
  • Company report
  • April 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ZymoGenetics, a wholly-owned subsidiary of Bristol-Myers ...

  • Industries : Biopharmaceutical
  • Countries : United States
Microbial Products: Technologies, Applications and Global Markets

Microbial Products: Technologies, Applications and Global Markets

  • $ 5 450
  • Industry report
  • April 2011
  • by BCC Research

An overview of the microbial products market, including a general description of commercial microbes that are bought and sold on the market or used to produce products. Analysis of global market trends, ...

  • Industries : Biotechnology
Top 10 Healthcare Trends in 2011

Top 10 Healthcare Trends in 2011

  • $ 3 500
  • Industry report
  • March 2011
  • by GBI Research

Top 10 Healthcare Trends in 2011 Summary GBI Research has released its latest report, ?Top 10 Healthcare Trends in 2011? that provides key data, information and analysis of the major trends in the biopharmaceutical ...

  • Industries : Biopharmaceutical
  • Countries : World
Biomaterials that Deliver Antimicrobials: An Overview

Biomaterials that Deliver Antimicrobials: An Overview

  • $ 500
  • Industry report
  • March 2011
  • by Global Data

The report provides key industry ed products, key players and industry dynamics. The report provides comprehensive data on the industry drivers and restraints affecting the industry growth. Scope of the ...

  • Industries : Biomaterial
  • Countries : United States
Biopharmaceutical in Australia: CSL Limited

Biopharmaceutical in Australia: CSL Limited

  • $ 175
  • Company report
  • March 2011
  • by MarketLine

- SWOT Analysis examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. (CSL) is a biopharmaceutical group ...

  • Industries : Biopharmaceutical
  • Countries : Australia

» Download Public Reports

About 9 000 reports
Company Report: Biological Therapy in The United States for Year 2013

Company Report: Biological Therapy in The United States for Year 2013

  • Company report
  • April 2013
  • 17 pages

... From funding. The doc/nist will review research using human embryonic stem cell lines that it supports and conducts in accordance with the common rule and nist implementing procedures, as appropriate ...


» Read our Company Profiles

99 Companies

Nutrition Co.

United States

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.